Bayer closing down San Francisco research hub as attention turns to Berkeley plan
Bayer is saying farewell to a longtime research hub in San Francisco, centralizing US efforts in the Boston area and potentially leaving several biotechs in its incubator without a home.
The German drug giant will shut down the “innovation hub” and CoLaborator incubator ahead of its lease expiring in October, a Bayer spokesperson told Endpoints. Once a location thought of as pivotal to Bayer’s US plans, the San Francisco site will shutter after more than a decade of operation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.